Arrowhead Pharmaceuticals, Inc. (FRA:HDP1)

Arrowhead Pharmaceuticals Revenue

In the fiscal year ending September 30, 2025, Arrowhead Pharmaceuticals had annual revenue of $829.45M USD with 23,258.15% growth. Arrowhead Pharmaceuticals had revenue of $256.47M in the quarter ending September 30, 2025.

• Revenue: $829.45M
• Revenue Growth: +23,258.15%
• P/S Ratio: 9.30
• Revenue / Employee: $1.17M
• Employees: 711
• Market Cap: 6.57B EUR

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Sep 30, 2025	829.45M	825.90M	23,258.15%
Sep 30, 2024	3.55M	-237.18M	-98.52%
Sep 30, 2023	240.74M	-2.50M	-1.03%
Sep 30, 2022	243.23M	104.94M	75.89%
Sep 30, 2021	138.29M	50.30M	57.16%
Sep 30, 2020	87.99M	-80.80M	-47.87%
Sep 30, 2019	168.80M	152.65M	945.67%
Sep 30, 2018	16.14M	-15.27M	-48.60%
Sep 30, 2017	31.41M	31.25M	19,736.49%
Sep 30, 2016	158.33K	-223.67K	-58.55%
Sep 30, 2015	382.00K	207.00K	118.29%
Sep 30, 2014	175.00K	-115.27K	-39.71%
Sep 30, 2013	290.27K	143.39K	97.63%
Sep 30, 2012	146.88K	-149.26K	-50.40%
Sep 30, 2011	296.14K	-	-
Sep 30, 2010	-	-	-
Sep 30, 2009	3.76M	2.45M	188.38%
Sep 30, 2008	1.30M	-2.50M	-65.69%
Sep 30, 2007	3.80M	3.20M	537.91%
Sep 30, 2006	595.46K	4.78K	0.81%
Sep 30, 2005	590.68K	-	-